Brief: Brainsway Launches First Clinical Trial Of Deep Tms 360™ System For Alcohol Use Disorder
17/11/2025 12:48
Brainsway Ltd BWAY.TA: BRAINSWAY LAUNCHES FIRST CLINICAL TRIAL OF DEEP TMS 360™ SYSTEM FOR ALCOHOL USE DISORDER Source text: ID:nGNXcCgfB Further company coverage: BWAY.TA
Recent news on Brainsway
See all newsBrief: Brainsway Presents Positive Data From Largest Real-World Study Of Deep Tms™ In Patients With Comorbid Ptsd And Major Depressive Disorder
Brief: Brainsway Announces Minority-Stake Investment In Hopemark Health
Brief: Brainsway Announces New Minority-Stake Investment In Canadian Provider, Brainstim Health Inc.
Brief: Brainsway Announces Change In ADS-To-Ordinary Share Ratio
Brief: BrainsWay Announces FDA Approval of Neurolief’s Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD)